Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing COVID-19-associated Thrombosis, Coagulopathy and Mortality With Low- and High-dose Anticoagulation: a Multicentric Randomized, Open-label Clinical Trial

NCT04345848 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT04345848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04345848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing COVID-19-associated Thrombosis, Coagulopathy and Mortality With Low- and High-dose Anticoagulation: a Multicentric Randomized, Open-label Clinical Trial
Lead sponsor
University Hospital, Geneva
Phase
Phase 3
Overall status
Terminated
Start date
April 28, 2020
Completion date
June 2, 2021
Enrollment
160 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid, sars-cov2